Gabelli Funds’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.74M | Sell |
189,900
-14,900
| -7% | -$215K | 0.02% | 661 |
|
|
2025
Q1 | $1.41M | Buy |
204,800
+14,800
| +8% | +$102K | 0.01% | 715 |
|
|
2024
Q4 | $1.01M | Sell |
190,000
-10,000
| -5% | -$53.1K | 0.01% | 783 |
|
|
2024
Q3 | $730K | Hold |
200,000
| – | – | 0.01% | 841 |
|
|
2024
Q2 | $546K | Hold |
200,000
| – | – | ﹤0.01% | 883 |
|
|
2024
Q1 | $696K | Hold |
200,000
| – | – | 0.01% | 845 |
|
|
2023
Q4 | $286K | Buy |
200,000
+20,000
| +11% | +$28.6K | ﹤0.01% | 960 |
|
|
2023
Q3 | $263K | Buy |
180,000
+15,000
| +9% | +$21.9K | ﹤0.01% | 984 |
|
|
2023
Q2 | $259K | Buy |
165,000
+8,200
| +5% | +$12.9K | ﹤0.01% | 990 |
|
|
2023
Q1 | $240K | Buy |
156,800
+104,800
| +202% | +$160K | ﹤0.01% | 1017 |
|
|
2022
Q4 | $87.4K | Buy |
52,000
+24,000
| +86% | +$40.3K | ﹤0.01% | 1112 |
|
|
2022
Q3 | $34K | Buy |
+28,000
| New | +$34K | ﹤0.01% | 1227 |
|